Goldshtein H, Muhire A, Petel Légaré V, Pushett A, Rotkopf R, Shefner J, et al. Efficacy of Ciprofloxacin/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2020;7:1883-1897 pubmed publisher

Chern C, Zhou H, Wang Y, Chang C, Chiou W, Chang W, et al. Osthole ameliorates cartilage degradation by downregulation of NF-κB and HIF-2α pathways in an osteoarthritis murine model. Eur J Pharmacol. 2020;867:172799 pubmed publisher

Gassen N, Niemeyer D, Muth D, Corman V, Martinelli S, Gassen A, et al. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection. Nat Commun. 2019;10:5770 pubmed publisher

Sagar S, Singh D, Das R, Panchal N, Sudarsanam V, Nivsarkar M, et al. Pharmacological investigation of quinoxaline-bisthiazoles as multitarget-directed ligands for the treatment of Alzheimer's disease. Bioorg Chem. 2019;89:102992 pubmed publisher

König S, Romp E, Krauth V, Rühl M, Dörfer M, Liening S, et al. Melleolides from Honey Mushroom Inhibit 5-Lipoxygenase via Cys159. Cell Chem Biol. 2019;26:60-70.e4 pubmed publisher

Li Y, Soendergaard C, Bergenheim F, Aronoff D, Milne G, Riis L, et al. COX-2-PGE2 Signaling Impairs Intestinal Epithelial Regeneration and Associates with TNF Inhibitor Responsiveness in Ulcerative Colitis. EBioMedicine. 2018;36:497-507 pubmed publisher

Liu R, Zheng H, Li W, Guo Q, He S, Hirasaki Y, et al. Anti-tumor enhancement of Fei-Liu-Ping ointment in combination with celecoxib via cyclooxygenase-2-mediated lung metastatic inflammatory microenvironment in Lewis lung carcinoma xenograft mouse model. J Transl Med. 2015;13:366 pubmed publisher

Zhou X, Shi X, Ren K, Fan G, Wu S, Zhao J. Celecoxib inhibits cell growth and modulates the expression of matrix metalloproteinases in human osteosarcoma MG-63 cell line. Eur Rev Med Pharmacol Sci. 2015;19:4087-97 pubmed

Zhang L, Tong Y, Zhang X, Pan M, Chen S. Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth. Drug Des Devel Ther. 2015;9:5851-62 pubmed publisher

Qin G, Xu F, Qin T, Zheng Q, Shi D, Xia W, et al. Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway. Oncotarget. 2015;6:41794-808 pubmed publisher

Wu G, Wu N, Li T, Fan Y, Yu G, Lu W. Effect of Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood on reproductive endocrine activity and immune functions in patients with primary Sjogren's syndrome. Chin J Integr Med. 2015;21:778-83 pubmed publisher

Schellhorn M, Haustein M, Frank M, Linnebacher M, Hinz B. Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1. Oncotarget. 2015;6:39342-56 pubmed publisher

Rosenblat J, McIntyre R, Alves G, Fountoulakis K, Carvalho A. Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review. Curr Neuropharmacol. 2015;13:636-55 pubmed

Li N, Li H, Su F, Li J, Ma X, Gong P. Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells. Int J Clin Exp Pathol. 2015;8:9010-20 pubmed

Syed H, Ikram M, Yaqinuddin A, Ahmed T. Cyclooxygenase I and II inhibitors distinctly enhance hippocampal- and cortex-dependent cognitive functions in mice. Mol Med Rep. 2015;12:7649-56 pubmed publisher

Iqbal M, Ezzeldin E, Bhat M, Raish M, Al Rashood K. Preclinical pharmacokinetics, tissue distribution and excretion studies of a novel anti-candidal agent-thiosemicarbazide derivative of isoniazid (TSC-INH) by validated UPLC-MS/MS assay. J Pharm Biomed Anal. 2016;117:109-17 pubmed publisher

Cataldi M, Shah N, Felt S, Grdzelishvili V. Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1. Virology. 2015;485:340-54 pubmed publisher

Sobolewski C, Rhim J, Legrand N, Muller F, Cerella C, Mack F, et al. 2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells. J Pharmacol Exp Ther. 2015;355:308-28 pubmed publisher

Ma Y, Gao S, Hu M. Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1001:202-11 pubmed publisher

Whitted C, Palau V, Torrenegra R, Harirforoosh S. Development of reversed-phase high performance liquid chromatography methods for quantification of two isomeric flavones and the application of the methods to pharmacokinetic studies in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1001:150-5 pubmed publisher

Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, et al. Efficacy of Direct Injection of Etanercept into Knee Joints for Pain in Moderate and Severe Knee Osteoarthritis. Yonsei Med J. 2015;56:1379-83 pubmed publisher

Lee Y, Kim J, Kim W, Nam J, Jeong S, Lee S, et al. Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery. Drug Des Devel Ther. 2015;9:4105-13 pubmed publisher

Ko H, Ahn E, Oh J. N‑trans‑ρ‑caffeoyl tyramine isolated from Tribulus terrestris exerts anti‑inflammatory effects in lipopolysaccharide‑stimulated RAW 264.7 cells. Int J Mol Med. 2015;36:1042-8 pubmed publisher

Liu D, Guo M, Hu Y, Liu T, Yan J, Luo Y, et al. Effect of sanhuangwuji powder, anti-rheumatic drugs, and ginger-partitioned acupoint stimulation on the treatment of rheumatoid arthritis with peptic ulcer: a randomized controlled study. J Tradit Chin Med. 2015;35:273-80 pubmed

Tian S, Chang W, Du H, Bai J, Sun Z, Zhang Q, et al. The interplay between GRP78 expression and Akt activation in human colon cancer cells under celecoxib treatment. Anticancer Drugs. 2015;26:964-73 pubmed publisher

Jung Y, Kim E, Choi H, Park J, Kim H, Lee Y, et al. Aspirin Targets SIRT1 and AMPK to Induce Senescence of Colorectal Carcinoma Cells. Mol Pharmacol. 2015;88:708-19 pubmed publisher

Liu N, Chen L, Cai N. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy. Int J Clin Exp Pathol. 2015;8:4990-8 pubmed

Khan N, Farooq A, Sadek B. Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists. Drug Des Devel Ther. 2015;9:3497-506 pubmed publisher

Tang J, Xiao W, Li Q, Deng Q, Chu X, Chen Y, et al. A Cyclooxygenase-2 Inhibitor Reduces Vascular Wall Thickness and Ameliorates Cognitive Impairment in a Cerebral Small Vessel Diseases Rat Model. Curr Alzheimer Res. 2015;12:704-10 pubmed

Mohammadinejad P, Arya P, Esfandbod M, Kaviani A, Najafi M, Kashani L, et al. Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients: A Double-Blind, Placebo-Controlled, Randomized Trial. Ann Pharmacother. 2015;49:953-61 pubmed publisher

Xu Z, Zhang R, Zhang D, Yao J, Shi R, Tang Q, et al. Peptic ulcer hemorrhage combined with acute gout: analyses of treatment in 136 cases. Int J Clin Exp Med. 2015;8:6193-9 pubmed

Hiyama A, Yokoyama K, Nukaga T, Sakai D, Mochida J. Response to tumor necrosis factor-α mediated inflammation involving activation of prostaglandin E2 and Wnt signaling in nucleus pulposus cells. J Orthop Res. 2015;33:1756-68 pubmed publisher

Ichikawa M, Sowa Y, Iizumi Y, Aono Y, Sakai T. Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells. PLoS ONE. 2015;10:e0129851 pubmed publisher

Wei G, Chen X, Wang G, Jia P, Xu Q, Ping G, et al. Inhibition of cyclooxygenase-2 prevents intra-abdominal adhesions by decreasing activity of peritoneal fibroblasts. Drug Des Devel Ther. 2015;9:3083-98 pubmed publisher

Gu J, Zhang X, Ma Y, Li N, Luo F, Cao L, et al. Quantitative modeling of dose-response and drug combination based on pathway network. J Cheminform. 2015;7:19 pubmed publisher

Olive D, Barrington M, Simone S, Kluger R. A randomised controlled trial comparing three analgesia regimens following total knee joint replacement: continuous femoral nerve block, intrathecal morphine or both. Anaesth Intensive Care. 2015;43:454-60 pubmed

Costa Nunes J, Cline B, Araújo Correia M, Valença A, Markova N, Dolgov O, et al. Animal Models of Depression and Drug Delivery with Food as an Effective Dosing Method: Evidences from Studies with Celecoxib and Dicholine Succinate. Biomed Res Int. 2015;2015:596126 pubmed publisher

Liu J, Wu J, Zhou L, Pan C, Zhou Y, Du W, et al. ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib. Oncotarget. 2015;6:21341-52 pubmed

Nath S, Roy L, Grover P, Rao S, Mukherjee P. Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer. Pancreas. 2015;44:909-17 pubmed publisher

Jafari S, Ashrafizadeh S, Zeinoddini A, Rasoulinejad M, Entezari P, Seddighi S, et al. Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial. J Clin Pharm Ther. 2015;40:441-6 pubmed publisher

Maji S, Samal S, Pattanaik L, Panda S, Quinn B, Das S, et al. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas. Oncotarget. 2015;6:16623-37 pubmed

Gjyshi O, Roy A, Dutta S, Veettil M, Dutta D, Chandran B. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression. J Virol. 2015;89:7874-92 pubmed publisher

Venè R, Tosetti F, Minghelli S, Poggi A, Ferrari N, Benelli R. Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation. Oncotarget. 2015;6:12310-25 pubmed

Carpi S, Fogli S, Romanini A, Pellegrino M, Adinolfi B, Podestà A, et al. AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells. Anticancer Drugs. 2015;26:754-62 pubmed publisher

Li S, Gu Z, Xiao Z, Zhou T, Li J, Sun K. Anti-tumor effect and mechanism of cyclooxygenase-2 inhibitor through matrix metalloproteinase 14 pathway in PANC-1 cells. Int J Clin Exp Pathol. 2015;8:1737-42 pubmed

Tsai W, Ou T, Yen J, Wu C, Tung Y. Long-term frequent use of non-steroidal anti-inflammatory drugs might protect patients with ankylosing spondylitis from cardiovascular diseases: a nationwide case-control study. PLoS ONE. 2015;10:e0126347 pubmed publisher

Bryden L, Nicholson J, Doods H, Pekcec A. Deficits in spontaneous burrowing behavior in the rat bilateral monosodium iodoacetate model of osteoarthritis: an objective measure of pain-related behavior and analgesic efficacy. Osteoarthritis Cartilage. 2015;23:1605-12 pubmed publisher

Ambadapadi S, Wang P, Palii S, James M. Celecoxib influences steroid sulfonation catalyzed by human recombinant sulfotransferase 2A1. J Steroid Biochem Mol Biol. 2015;152:101-13 pubmed publisher

Shalbafan M, Mohammadinejad P, Shariat S, Alavi K, Zeinoddini A, Salehi M, et al. Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial. Pharmacopsychiatry. 2015;48:136-40 pubmed publisher

Chen J, Jiang L, Lan K, Chen X. Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK. Viruses. 2015;7:2268-87 pubmed publisher

Lee S, Koo B, Park S, Kim Y. Anti-angiogenic effects of resveratrol in combination with 5-fluorouracil on B16 murine melanoma cells. Mol Med Rep. 2015;12:2777-83 pubmed publisher

Behr C, Hesketh A, Barlow M, Glick R, Symons M, Steinberg B, et al. Celecoxib inhibits Ewing sarcoma cell migration via actin modulation. J Surg Res. 2015;198:424-33 pubmed publisher

Ren J, Huang H, Liu Y, Zheng X, Zou Q. An Atomic Force Microscope Study Revealed Two Mechanisms in the Effect of Anticancer Drugs on Rate-Dependent Young's Modulus of Human Prostate Cancer Cells. PLoS ONE. 2015;10:e0126107 pubmed publisher

Vlachopoulos C, Aznaouridis K, Bratsas A, Ioakeimidis N, Dima I, Xaplanteris P, et al. Arterial stiffening and systemic endothelial activation induced by smoking: The role of COX-1 and COX-2. Int J Cardiol. 2015;189:293-8 pubmed publisher

Kaserer T, Temml V, Kutil Z, Vanek T, Landa P, Schuster D. Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2. Eur J Med Chem. 2015;96:445-57 pubmed publisher

Ma H, Lu T, Zhang X, Li C, Xiong J, Huang L, et al. HSPA12B: a novel facilitator of lung tumor growth. Oncotarget. 2015;6:9924-36 pubmed

Jennings C, MacDonald T, Wei L, Brown M, McConnachie L, Mackenzie I. Does offering an incentive payment improve recruitment to clinical trials and increase the proportion of socially deprived and elderly participants?. Trials. 2015;16:80 pubmed publisher

Olesch C, Sha W, Angioni C, Sha L, Açaf E, Patrignani P, et al. MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer. Oncotarget. 2015;6:10284-96 pubmed

Kwong W, Liuni A, Zhou K, Parker J. Cyclooxygenase inhibition and rosuvastatin-induced vascular protection in the setting of ischemia-reperfusion: A human in vivo study. Vascul Pharmacol. 2015;71:159-65 pubmed publisher

Chien P, Lin C, Hsiao L, Yang C. c-Src/Pyk2/EGFR/PI3K/Akt/CREB-activated pathway contributes to human cardiomyocyte hypertrophy: Role of COX-2 induction. Mol Cell Endocrinol. 2015;409:59-72 pubmed publisher

Kim J, Ahmadinia K, Li X, Hamilton J, Andrews S, Haralampus C, et al. Development of an Experimental Animal Model for Lower Back Pain by Percutaneous Injury-Induced Lumbar Facet Joint Osteoarthritis. J Cell Physiol. 2015;230:2837-47 pubmed publisher

Jeon Y, Ahn Y, Chung W, Choi H, Suh Y. Synergistic effect between celecoxib and luteolin is dependent on estrogen receptor in human breast cancer cells. Tumour Biol. 2015;36:6349-59 pubmed publisher

Murdande S, Shah D, Dave R. Impact of nanosizing on solubility and dissolution rate of poorly soluble pharmaceuticals. J Pharm Sci. 2015;104:2094-2102 pubmed publisher

Xia Q, Hu Q, Wang H, Yang H, Gao F, Ren H, et al. Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia. Cell Death Dis. 2015;6:e1702 pubmed publisher

Mao Y, Xu J, Seeley E, Tang X, Xu L, Zhu Y, et al. Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Pulmonary Infection Caused by Pseudomonas aeruginosa via Inhibiting Overproduction of Prostaglandin E2. Stem Cells. 2015;33:2331-42 pubmed publisher

Li B, Su K, Yang G, Feng Y, Xia L, Yin S. Assessment of the potential ototoxicity of high-dose celecoxib, a selective cyclooxygenase-2 inhibitor, in rats. Otolaryngol Head Neck Surg. 2015;152:1108-12 pubmed publisher

Yang Y, Yan J, Huang Y, Xu H, Zhang Y, Hu R, et al. The cancer pain related factors affected by celecoxib together with cetuximab in head and neck squamous cell carcinoma. Biomed Pharmacother. 2015;70:181-9 pubmed publisher

Chang C, Cheng C, Yang T, Chen Y, Lin Y, Chen S, et al. Selective and non-selective non-steroidal anti-inflammatory drugs differentially regulate pulmonary vein and atrial arrhythmogenesis. Int J Cardiol. 2015;184:559-67 pubmed publisher

Bujalska Zadrożny M, de Cordé A, Pawlik K. Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy. Pharmacol Rep. 2015;67:209-16 pubmed publisher

Chung K, Lee J, Park J, Choi C. Risk factors of delirium in patients undergoing total knee arthroplasty. Arch Gerontol Geriatr. 2015;60:443-7 pubmed publisher

Cao Y, Qu J, Li C, Yang D, Hou K, Zheng H, et al. Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway. Tumour Biol. 2015;36:5607-15 pubmed publisher

Fantappiè O, Sassoli C, Tani A, Nosi D, Marchetti S, Formigli L, et al. Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane. J Cell Mol Med. 2015;19:1410-7 pubmed publisher

Sha L, Sha W, Kuchler L, Daiber A, Giegerich A, Weigert A, et al. Loss of Nrf2 in bone marrow-derived macrophages impairs antigen-driven CD8(+) T cell function by limiting GSH and Cys availability. Free Radic Biol Med. 2015;83:77-88 pubmed publisher

Li Z, Meng D, Li G, Xu J, Tian K, Li Y. Celecoxib Combined with Diacerein Effectively Alleviates Osteoarthritis in Rats via Regulating JNK and p38MAPK Signaling Pathways. Inflammation. 2015;38:1563-72 pubmed publisher

Balansky R, Ganchev G, Iltcheva M, Nikolov M, La Maestra S, Micale R, et al. Modulation by licofelone and celecoxib of experimentally induced cancer and preneoplastic lesions in mice exposed to cigarette smoke. Curr Cancer Drug Targets. 2015;15:188-95 pubmed

Thill M, Woeste A, Reichert K, Fischer D, Rody A, Friedrich M, et al. Vitamin D inhibits ovarian cancer cell line proliferation in combination with celecoxib and suppresses cyclooxygenase-2 expression. Anticancer Res. 2015;35:1197-203 pubmed

Zhang P, Cheng J, Zou S, D Souza A, Koff J, Lu J, et al. Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammation. Nat Commun. 2015;6:6221 pubmed publisher

El Mas M, Helmy M, Ali R, El Gowelli H. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling. Toxicol Appl Pharmacol. 2015;284:1-7 pubmed publisher

Aguado A, Rodriguez C, Martinez Revelles S, Avendaño M, Zhenyukh O, Orriols M, et al. HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration. Br J Pharmacol. 2015;172:3028-42 pubmed publisher

Li S, Xu X, Jiang M, Bi Y, Xu J, Han M. Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway. Mol Med Rep. 2015;11:4454-62 pubmed publisher

Iqbal M, Ezzeldin E, Al Rashood K, Shakeel F. A validated UPLC-MS/MS assay using negative ionization mode for high-throughput determination of pomalidomide in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;983-984:76-82 pubmed publisher

Kim J, Chung S, Kim S, Byun Y. Enhanced Anti-Angiogenic Effect of Low Molecular Weight Heparin-Bile Acid Conjugates by Co-Administration of a Selective COX-2 Inhibitor. Pharm Res. 2015;32:2318-27 pubmed publisher

Oh H, Kim D, Lee S, Jung B. Simultaneous quantitative determination of celecoxib and its two metabolites using liquid chromatography-tandem mass spectrometry in alternating polarity switching mode. J Pharm Biomed Anal. 2015;107:32-9 pubmed publisher

Tamura D, Saito T, Murata K, Kawashima M, Asano R. Celecoxib exerts antitumor effects in canine mammary tumor cells via COX‑2‑independent mechanisms. Int J Oncol. 2015;46:1393-404 pubmed publisher

Homayouni A, Sadeghi F, Nokhodchi A, Varshosaz J, Afrasiabi Garekani H. Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods. Iran J Pharm Res. 2015;14:35-50 pubmed

Bannuru R, Schmid C, Kent D, Vaysbrot E, Wong J, McAlindon T. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162:46-54 pubmed publisher

Zhu H, Zhuang X, Liu S, Pi Z, Song F, Lin N, et al. Ultrahigh-performance liquid chromatography/tandem mass spectrometry method for evaluating enzyme activity and screening inhibitors of cyclooxygenase-2. Rapid Commun Mass Spectrom. 2014;28:1792-800 pubmed publisher

Aziz F, Yang X, Wang X, Yan Q. Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study. J Cancer Res Clin Oncol. 2015;141:1221-35 pubmed publisher

Gjyshi O, Flaherty S, Veettil M, Johnson K, Chandran B, Bottero V. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1. J Virol. 2015;89:2268-86 pubmed publisher

Posada M, Bacon J, Schneck K, Tirona R, Kim R, Higgins J, et al. Prediction of renal transporter mediated drug-drug interactions for pemetrexed using physiologically based pharmacokinetic modeling. Drug Metab Dispos. 2015;43:325-34 pubmed publisher

Fink S, Dawson D, Zhang Y, Kresak A, Lawrence E, Yang P, et al. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs. Carcinogenesis. 2015;36:291-8 pubmed publisher

Luna Munguia H, Salvamoser J, Pascher B, Pieper T, Getzinger T, Kudernatsch M, et al. Glutamate-mediated upregulation of the multidrug resistance protein 2 in porcine and human brain capillaries. J Pharmacol Exp Ther. 2015;352:368-78 pubmed publisher

Göbel C, Breitenbuecher F, Kalkavan H, Hähnel P, Kasper S, Hoffarth S, et al. Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity. Cell Death Dis. 2014;5:e1568 pubmed publisher

Shen K, Song Y, Chen I, Chong P, Liu S. Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide. Hum Vaccin Immunother. 2014;10:3241-50 pubmed publisher

Portillo J, Schwartz I, Zarini S, Bapputty R, Kern T, Gubitosi Klug R, et al. Proinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signaling. Invest Ophthalmol Vis Sci. 2014;55:8590-7 pubmed publisher

Bowers L, Brenner A, Hursting S, Tekmal R, deGraffenried L. Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production. Breast Cancer Res Treat. 2015;149:49-57 pubmed publisher

Kurtova A, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, Lerner S, et al. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature. 2015;517:209-13 pubmed publisher

Ha E, Ok J, Noh J, Jeong H, Choo G, Jung Y, et al. Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant. Int J Biol Macromol. 2015;72:1473-8 pubmed publisher

Setia S, Nehru B, Sanyal S. Celecoxib prevents colitis associated colon carcinogenesis: an upregulation of apoptosis. Pharmacol Rep. 2014;66:1083-91 pubmed publisher

Liu R, Zheng J, Li C, Pang Y, Zheng Q, Xu X, et al. Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression. Arch Gynecol Obstet. 2015;291:1361-9 pubmed publisher

Hutchison M, White P. Prostacyclin regulates bone growth via the Epac/Rap1 pathway. Endocrinology. 2015;156:499-510 pubmed publisher

Nagata N, Niikura R, Sekine K, Sakurai T, Shimbo T, Kishida Y, et al. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study. J Gastroenterol Hepatol. 2015;30:292-8 pubmed publisher

Liu S, Jiang M, Zhao Q, Li S, Peng Y, Zhang P, et al. Vascular endothelial growth factor plays a critical role in the formation of the pre-metastatic niche via prostaglandin E2. Oncol Rep. 2014;32:2477-84 pubmed publisher

Hua K, Chou J, Ka S, Tasi Y, Chen A, Wu S, et al. Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1β production. J Cell Physiol. 2015;230:863-74 pubmed publisher

More A, Kim H, Khang G, Hildebrandt T, Bernlöhr C, Doods H, et al. Des-Arg9-bradykinin causes kinin B1 receptor mediated endothelium-independent contractions in endotoxin-treated porcine coronary arteries. Pharmacol Res. 2014;90:18-24 pubmed publisher

Ji Y, Seo Y, Choi W, Yeo A, Noh H, Kim E, et al. Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities. Invest Ophthalmol Vis Sci. 2014;55:6829-38 pubmed publisher

Cillo J, Dattilo D. Pre-emptive analgesia with pregabalin and celecoxib decreases postsurgical pain following maxillomandibular advancement surgery: a randomized controlled clinical trial. J Oral Maxillofac Surg. 2014;72:1909-14 pubmed publisher

Li C, Li C, Zhang A, To K, Lee A, Zhu H, et al. Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor. PLoS ONE. 2014;9:e107966 pubmed publisher

Kim S, Ha G, Bae J, Kim G, Son C, Park Y, et al. COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cells. Exp Cell Res. 2015;330:451-9 pubmed publisher

Hsu C, Lee I, Lin C, Hsiao L, Yang C. Sphingosine-1-phosphate mediates COX-2 expression and PGE2 /IL-6 secretion via c-Src-dependent AP-1 activation. J Cell Physiol. 2015;230:702-15 pubmed publisher

More A, Kim H, Zhao R, Khang G, Hildebrandt T, Bernlöhr C, et al. COX-2 mediated induction of endothelium-independent contraction to bradykinin in endotoxin-treated porcine coronary artery. J Cardiovasc Pharmacol. 2014;64:209-17 pubmed publisher

Rabinow B, Werling J, Bendele A, Gass J, Bogseth R, Balla K, et al. Intra-articular (IA) ropivacaine microparticle suspensions reduce pain, inflammation, cytokine, and substance p levels significantly more than oral or IA celecoxib in a rat model of arthritis. Inflammation. 2015;38:40-60 pubmed publisher

Dolkart O, Liron T, Chechik O, Somjen D, Brosh T, Maman E, et al. Statins enhance rotator cuff healing by stimulating the COX2/PGE2/EP4 pathway: an in vivo and in vitro study. Am J Sports Med. 2014;42:2869-76 pubmed publisher

Gao Z, Zhang H, Liu J, Lau C, Liu P, Chen Z, et al. Cyclooxygenase-2-dependent oxidative stress mediates palmitate-induced impairment of endothelium-dependent relaxations in mouse arteries. Biochem Pharmacol. 2014;91:474-82 pubmed publisher

Yoo M, Yoo W, Kang S, Park Y, Kim S, Moon K, et al. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial. Curr Med Res Opin. 2014;30:2399-408 pubmed publisher

Anwar Mohamed A, Barakat K, Bhat R, Noskov S, Tyrrell D, Tuszynski J, et al. A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity. Toxicol Lett. 2014;230:382-92 pubmed publisher

Bowers L, Maximo I, Brenner A, Beeram M, Hursting S, Price R, et al. NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions. Cancer Res. 2014;74:4446-57 pubmed publisher

Malvezi A, Panis C, da Silva R, de Freitas R, Lovo Martins M, Tatakihara V, et al. Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response. Antimicrob Agents Chemother. 2014;58:6157-64 pubmed publisher

Kim H, Ryu H, Kim J, Kim Y, Lee H, Jung J, et al. Validation of cyclooxygenase-2 as a direct anti-inflammatory target of 4-O-methylhonokiol in zymosan-induced animal models. Arch Pharm Res. 2015;38:813-25 pubmed publisher

Vera M, Barcia E, Negro S, Marcianes P, Garcia Garcia L, Slowing K, et al. New celecoxib multiparticulate systems to improve glioblastoma treatment. Int J Pharm. 2014;473:518-27 pubmed publisher

Lin T, Lu C, Wang C, Huang S, Wang S. Cyclooxygenase 2 inhibitor celecoxib inhibits glutamate release by attenuating the PGE2/EP2 pathway in rat cerebral cortex endings. J Pharmacol Exp Ther. 2014;351:134-45 pubmed publisher

. In brief: generic celecoxib. Med Lett Drugs Ther. 2014;56:59 pubmed

Ho V, Hamilton M, Dang N, Hsu B, Adomat H, Guns E, et al. A low carbohydrate, high protein diet combined with celecoxib markedly reduces metastasis. Carcinogenesis. 2014;35:2291-9 pubmed publisher

INGE L, Friel J, Richer A, Fowler A, Whitsett T, Smith M, et al. LKB1 inactivation sensitizes non-small cell lung cancer to pharmacological aggravation of ER stress. Cancer Lett. 2014;352:187-95 pubmed publisher

Xiang H, Xie X, Hu F, Xiao H, Zhang W, Chen L. Cyclooxygenase-2 inhibition as a strategy for treating gastric adenocarcinoma. Oncol Rep. 2014;32:1140-8 pubmed publisher

Huang H, Cui X, Chen S, Goodin S, Liu Y, He Y, et al. Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo. Anticancer Res. 2014;34:3357-63 pubmed

Majumder M, Xin X, Liu L, Girish G, Lala P. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions. Cancer Sci. 2014;105:1142-51 pubmed publisher

Ishak R, Mortada N, Zaki N, El Shamy A, Awad G. Impact of microparticle formulation approaches on drug burst release: a level A IVIVC. J Microencapsul. 2014;31:674-84 pubmed publisher

Wu H, Cabral H, Toh K, Mi P, Chen Y, Matsumoto Y, et al. Polymeric micelles loaded with platinum anticancer drugs target preangiogenic micrometastatic niches associated with inflammation. J Control Release. 2014;189:1-10 pubmed publisher

Zhang K, Zhang S, Li Q, Yang J, Dong W, Wang S, et al. Effects of celecoxib on proliferation and tenocytic differentiation of tendon-derived stem cells. Biochem Biophys Res Commun. 2014;450:762-6 pubmed publisher

Homayouni A, Sadeghi F, Varshosaz J, Garekani H, Nokhodchi A. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. Eur J Pharm Biopharm. 2014;88:261-74 pubmed publisher

Zheng S, Liao S, Zou Y, Qu Z, Liu F. ins-7 Gene expression is partially regulated by the DAF-16/IIS signaling pathway in Caenorhabditis elegans under celecoxib intervention. PLoS ONE. 2014;9:e100320 pubmed publisher

Darwish H, Arab H, Abdelsalam R. Chrysin alleviates testicular dysfunction in adjuvant arthritic rats via suppression of inflammation and apoptosis: comparison with celecoxib. Toxicol Appl Pharmacol. 2014;279:129-40 pubmed publisher

Wong T, Li F, Lin S, Chan F, Chen S, Leung L. Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice. BMC Cancer. 2014;14:426 pubmed publisher

Lin C, Hsieh H, Liu S, Tseng H, Hsiao L, Yang C. BK Induces cPLA2 Expression via an Autocrine Loop Involving COX-2-Derived PGE2 in Rat Brain Astrocytes. Mol Neurobiol. 2015;51:1103-15 pubmed publisher

Wen S, Gao J, Yang W, Lu Y, Tong H, Huang Z, et al. Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes. J Gastroenterol Hepatol. 2014;29:1932-42 pubmed publisher

Steinke J, Negri J, Liu L, Payne S, Borish L. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease. J Immunol. 2014;193:41-7 pubmed publisher

Fujii R, Imanishi Y, Shibata K, Sakai N, Sakamoto K, Shigetomi S, et al. Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 2014;33:40 pubmed publisher

Fernandez Martinez A, Torija A, Carracedo J, Ramirez R, de Lucio Cazaña F. Microparticles released by vascular endothelial cells increase hypoxia inducible factor expression in human proximal tubular HK-2 cells. Int J Biochem Cell Biol. 2014;53:334-42 pubmed publisher

Cheng G, Zielonka J, McAllister D, Tsai S, Dwinell M, Kalyanaraman B. Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. Br J Cancer. 2014;111:85-93 pubmed publisher

Bell E, Ponthan F, Whitworth C, Tweddle D, Lunec J, Redfern C. COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib. Clin Exp Metastasis. 2014;31:651-9 pubmed publisher

Lee J, Chung K, Choi C. The effect of a single dose of preemptive pregabalin administered with COX-2 inhibitor: a trial in total knee arthroplasty. J Arthroplasty. 2015;30:38-42 pubmed publisher

Haider S, Alam M, Hamid H, Shafi S, Dhulap A, Hussain F, et al. Synthesis of novel 2-mercaptobenzoxazole based 1,2,3-triazoles as inhibitors of proinflammatory cytokines and suppressors of COX-2 gene expression. Eur J Med Chem. 2014;81:204-17 pubmed publisher

Liu M, Saeki K, Matsunobu T, Okuno T, Koga T, Sugimoto Y, et al. 12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor. J Exp Med. 2014;211:1063-78 pubmed publisher

Duarte S, Kato H, Kuriyama N, Suko K, Ishikawa T, Busuttil R, et al. Hepatic ischemia and reperfusion injury in the absence of myeloid cell-derived COX-2 in mice. PLoS ONE. 2014;9:e96913 pubmed publisher

Shete G, Kuncham S, Puri V, Gangwal R, Sangamwar A, Bansal A. Effect of different "states" of sorbed water on amorphous celecoxib. J Pharm Sci. 2014;103:2033-2041 pubmed publisher

Yamawaki H, Mihara H, Suzuki N, Nishizono H, Uchida K, Watanabe S, et al. Role of transient receptor potential vanilloid 4 activation in indomethacin-induced intestinal damage. Am J Physiol Gastrointest Liver Physiol. 2014;307:G33-40 pubmed publisher

Harrison C. 18 months sliced off Celebrex's patent protection. Nat Rev Drug Discov. 2014;13:326 pubmed publisher

Chu T, Chan H, Kuo H, Liu L, Hu T, Sun C, et al. Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. Oncotarget. 2014;5:1475-90 pubmed

Cha W, Park S, Kwon T, Hah J, Sung M. Endoplasmic reticulum stress response as a possible mechanism of cyclooxygenase-2-independent anticancer effect of celecoxib. Anticancer Res. 2014;34:1731-5 pubmed

Pergola C, Gerstmeier J, Mönch B, Caliskan B, Luderer S, Weinigel C, et al. The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP). Br J Pharmacol. 2014;171:3051-64 pubmed publisher

Gallouet A, Travert M, Bresson Bepoldin L, Guilloton F, Pangault C, Caulet Maugendre S, et al. COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis. Clin Cancer Res. 2014;20:2663-73 pubmed publisher

Paech M, McDonnell N, Sinha A, Baber C, Nathan E. A randomised controlled trial of parecoxib, celecoxib and paracetamol as adjuncts to patient-controlled epidural analgesia after caesarean delivery. Anaesth Intensive Care. 2014;42:15-22 pubmed

Funahashi Y, O Malley K, Kawamorita N, Tyagi P, DeFranco D, Takahashi R, et al. Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation. Prostate. 2014;74:337-45 pubmed publisher

Wang L, Hsiao C, Chen W, Lee H, Lin T, Chen H, et al. Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study. J Surg Oncol. 2014;109:580-5 pubmed publisher

Altman R, Daniels S, Young C. Indomethacin submicron particle capsules provide effective pain relief in patients with acute pain: a phase 3 study. Phys Sportsmed. 2013;41:7-15 pubmed publisher

Zhu L, Ploessl K, Kung H. Chemistry. Expanding the scope of fluorine tags for PET imaging. Science. 2013;342:429-30 pubmed publisher

Derry S, Moore R. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2013;:CD004233 pubmed publisher

Garcia M, Velez R, Romagosa C, Majem B, Pedrola N, Olivan M, et al. Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice. BJU Int. 2014;113:E164-77 pubmed publisher

Short S, Wang J, Castle S, Fernandez G, Smiley N, Zobel M, et al. Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis. Lab Invest. 2013;93:1265-75 pubmed publisher

Robison N, Campigotto F, Chi S, Manley P, Turner C, Zimmerman M, et al. A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer. Pediatr Blood Cancer. 2014;61:636-42 pubmed publisher

Völzke A, Koch A, Meyer Zu Heringdorf D, Huwiler A, Pfeilschifter J. Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells. Biochim Biophys Acta. 2014;1841:11-21 pubmed publisher

Negi A, Kansal S, Bhatnagar A, Agnihotri N. Alteration in apoptosis and cell cycle by celecoxib and/or fish oil in 7,12-dimethyl benzene (α) anthracene-induced mammary carcinogenesis. Tumour Biol. 2013;34:3753-64 pubmed publisher

Qin W, Smith C, Jensen M, Holick M, Sauter E. Vitamin D favorably alters the cancer promoting prostaglandin cascade. Anticancer Res. 2013;33:3861-6 pubmed

Iyengar R, Gandhi S, Aneja A, Thorpe K, Razzouk L, Greenberg J, et al. NSAIDs are associated with lower depression scores in patients with osteoarthritis. Am J Med. 2013;126:1017.e11-8 pubmed publisher

Cha J, Bartos A, Egashira M, Haraguchi H, Saito Fujita T, Leishman E, et al. Combinatory approaches prevent preterm birth profoundly exacerbated by gene-environment interactions. J Clin Invest. 2013;123:4063-75 pubmed publisher

Cheng Q, Li N, Chen M, Zheng J, Qian Z, Wang X, et al. Cyclooxygenase-2 promotes hepatocellular apoptosis by interacting with TNF-α and IL-6 in the pathogenesis of nonalcoholic steatohepatitis in rats. Dig Dis Sci. 2013;58:2895-902 pubmed publisher

Dong L, Sharma N, Jurban B, Smith W. Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer. J Biol Chem. 2013;288:28641-55 pubmed publisher

Bhattacharya A, Li Y, Shi Y, Zhang Y. Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination. Carcinogenesis. 2013;34:2593-9 pubmed publisher

Crilly M, Mangoni A, Knights K. Aldosterone glucuronidation inhibition as a potential mechanism for arterial dysfunction associated with chronic celecoxib and diclofenac use in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2013;31:691-8 pubmed

Wang L, Bai L, Su D, Zhang T, Mao Z. Proinflammatory conditions promote hepatocellular carcinoma onset and progression via activation of Wnt and EGFR signaling pathways. Mol Cell Biochem. 2013;381:173-81 pubmed publisher

Udd L, Gao Y, Ristimaki A, Makela T. N-methylnitrosourea aggravates gastrointestinal polyposis in Lkb1+/- mice. Carcinogenesis. 2013;34:2409-14 pubmed publisher

Farooq F, Abadía Molina F, MacKenzie D, Hadwen J, Shamim F, O Reilly S, et al. Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation. Hum Mol Genet. 2013;22:3415-24 pubmed publisher

Mehta A, Hsiao W, King P, Schlegel P. Perioperative celecoxib decreases opioid use in patients undergoing testicular surgery: a randomized, double-blind, placebo controlled trial. J Urol. 2013;190:1834-8 pubmed publisher

Kumar V, Kaur K, Gupta G, Gupta A, Kumar S. Developments in synthesis of the anti-inflammatory drug, celecoxib: a review. Recent Pat Inflamm Allergy Drug Discov. 2013;7:124-34 pubmed

Elhoudzi J, Rome A, Padovani L, Gentet J, Andre N. Metronomic scheduling of anticancer agents for a refractory orbital pseudotumor in a child. J Pediatr Hematol Oncol. 2013;35:632-3 pubmed publisher

Huelin R, Pokora T, Foster T, Mould J. Economic outcomes for celecoxib: a systematic review of pharmacoeconomic studies. Expert Rev Pharmacoecon Outcomes Res. 2012;12:505-23 pubmed publisher

Piplani H, Vaish V, Rana C, Sanyal S. Up-regulation of p53 and mitochondrial signaling pathway in apoptosis by a combination of COX-2 inhibitor, Celecoxib and Dolastatin 15, a marine mollusk linear peptide in experimental colon carcinogenesis. Mol Carcinog. 2013;52:845-58 pubmed publisher

Derry S, Moore R. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2012;:CD004233 pubmed publisher

Winfield L, Payton Stewart F. Celecoxib and Bcl-2: emerging possibilities for anticancer drug design. Future Med Chem. 2012;4:361-83 pubmed publisher

McCormack P. Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Drugs. 2011;71:2457-89 pubmed publisher

Arakawa Y, Nakai N, Katoh N. Celecoxib-induced erythema multiforme-type drug eruption with a positive patch test. J Dermatol. 2011;38:1185-8 pubmed publisher

Zweers M, de Boer T, van Roon J, Bijlsma J, Lafeber F, Mastbergen S. Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis. Arthritis Res Ther. 2011;13:239 pubmed publisher

Mallen S, Essex M, Zhang R. Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs. Curr Med Res Opin. 2011;27:1359-66 pubmed publisher

Liu Y, Zhang W, Zhang X, Qi Y, Huang D, Zhang Y. Arsenic trioxide inhibits invasion/migration in SGC-7901 cells by activating the reactive oxygen species-dependent cyclooxygenase-2/matrix metalloproteinase-2 pathway. Exp Biol Med (Maywood). 2011;236:592-7 pubmed publisher

Jendrossek V. Targeting apoptosis pathways by Celecoxib in cancer. Cancer Lett. 2013;332:313-24 pubmed publisher

Sakamoto C, Soen S. Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan. Digestion. 2011;83:108-23 pubmed publisher

Mateos J. [Selective inhibitors of cyclooxygenase-2 (COX-2), celecoxib and parecoxib: a systematic review]. Drugs Today (Barc). 2010;46 Suppl A:1-25 pubmed

Amrite A, Pugazhenthi V, Cheruvu N, Kompella U. Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes. Expert Opin Drug Deliv. 2010;7:631-45 pubmed publisher

DuBois R. New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs. Cancer Prev Res (Phila). 2009;2:285-7 pubmed publisher

Fakih M, Rustum Y. Does celecoxib have a role in the treatment of patients with colorectal cancer?. Clin Colorectal Cancer. 2009;8:11-4 pubmed publisher

O Connor J, Lysz T. Celecoxib, NSAIDs and the skeleton. Drugs Today (Barc). 2008;44:693-709 pubmed publisher

Derry S, Barden J, McQuay H, Moore R. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2008;:CD004233 pubmed publisher

Poddubnyy D, Song I, Sieper J. The safety of celecoxib in ankylosing spondylitis treatment. Expert Opin Drug Saf. 2008;7:401-9 pubmed

Kimoto A, Hanaoka A, Sasamata M, Miyata K. [Pre-clinical and clinical profiles of celecoxib, a new specific cyclooxygenase-2 inhibitor]. Nihon Yakurigaku Zasshi. 2008;131:127-36 pubmed

Schonthal A, Chen T, Hofman F, Louie S, Petasis N. Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs. Expert Opin Investig Drugs. 2008;17:197-208 pubmed publisher

Zarghi A, Shafaati A, Foroutan S, Khoddam A. Simple and rapid high-performance liquid chromatographic method for determination of celecoxib in plasma using UV detection: application in pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;835:100-4 pubmed